GSK Consumer Healthcare (GSK) has issued a recall for several types of Excedrin over a child safety risk.

The affected Excedrin may have holes in the plastic bottles near the base that could allow children to access or swallow the caplets or geltabs inside. The bottles, which are child-resistant, were sold in 50-count and larger quantities and were packaged in cardboard cartons.

The recalled products include multiple lots of Excedrin Migraine Caplets and Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets.

A full list of affected products can be viewed here.

GSK is urging consumers to check their bottles of Excedrin to determine if they have holes. The company said the “likelihood there are bottles on the market with holes is low.”

Consumers that find a hole in their Excedrin bottle should contract GSK for a full refund at 1-800-468-7746, Monday through Friday from 8 a.m. to 6 p.m.

However, if a consumer finds that the bottle is not damaged, GSK said the product is safe for use.

“We take product safety very seriously at GSK and while we have not received any complaints or safety concerns to date on this potential problem, we are still letting consumers know so they can check their Excedrin bottles themselves,” the company said in a statement on its website.

“We sincerely apologize for any inconvenience, and please be assured we are working closely with the bottle manufacturer to fix this problem as quickly as we can.”

Shares of GSK were trading at $36.35 as of 1:20 p.m. EST, up 26 cents or 0.72%.

Another popular maintenance drug for preventing heart attack and stroke is now being questioned after a study revealed that it might be causing more harm than good to elderly patients. Pictured: Generic aspirin lie inside its bottle Getty Images/Tim Boyle